Pelvic exenteration for clinical T4 rectal cancer: Oncologic outcome in 93 patients at a single institution over a 30-year period

Surgery

Volumn 145, Issue 2, 2009, Pages 189-195

  Ishiguro, Seiji ^a,b   Akasu, Takayuki ^a   Fujita, Shin ^a   Yamamoto, Seiichiro ^a   Kusters, Miranda ^c   Moriya, Yoshihiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARMOFUR; CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; UFT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PELVIS EXENTERATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECTUM CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PELVIC EXENTERATION; PELVIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; RECTUM; RETROSPECTIVE STUDIES;

EID: 58349092918     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.09.014     Document Type: Article

References (29)

1. Moriya Y., Akasu T., Fujita S., and Yamamoto S. Aggressive surgical treatment for patients with T4 rectal cancer. Colorectal Dis 5 (2003) 427-431
2. American Joint Committee on Cancer. Colon and rectum. AJCC cancer staging manual. 6th ed (2002), Springer, New York
3. Moriya Y., Akasu T., Fujita S., and Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 47 (2004) 2047-2053
4. Hafner G.H., Herrera L., and Petrelli N.J. Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma. Ann Surg 215 (1992) 63-67
5. Yamamoto S., Fujita S., Akasu T., Uehara K., and Moriya Y. Reduction of prolonged postoperative hospital stay after laparoscopic surgery for colorectal carcinoma. Surg Endosc 20 (2006) 1467-1472
6. Moriya Y., Akasu T., Fujita S., and Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer. Surg Oncol Clin North Am 14 (2005) 225-238
7. Rodriguwz-Bigas M.A., and Petrelli N.J. Pelvic exenteration and its modifications. Am J Surg 171 (1996) 293-298
8. Kawasaki S., Makuuchi M., Kakazu T., Miyagawa S., Takayama T., Kosuge T., et al. Resection for multiple metastatic liver tumors after portal embolization. Surgery 115 (1994) 674-677
9. Hafner G.H., Herrera L., and Petrelli N.J. Patterns of recurrence after pelvic exenteration for colorectal adenocarcinoma. Arch Surg 126 (1991) 1510-1513
10. Lopez M.J., Kraybill W.G., Downey R.S., Johnston W.D., and Bricker E.M. Exenterative surgery for locally advanced rectosigmoid cancers. Is it worthwhile?. Surgery 102 (1987) 644-651
11. Pandey D., Zaidi S., Mahajan V., and Kannan R. Pelvic exenteration: a perspective from a regional cancer center in India. Indian J Cancer 41 (2004) 109-114
12. Law W.L., Chu K.W., and Choi H.K. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg 190 (2000) 78-83
13. Ike H., Shimada H., Yamaguchi S., Ichikawa Y., Fujii S., and Ohki S. Outcome of total pelvic exenteration for primary rectal cancer. Dis Colon Rectum 46 (2003) 474-480
14. Chen H.S., and Sheen-Chen S.M. Total pelvic exenteration for primary local advanced colorectal cancer. World J Surg 25 (2001) 1546-1549
15. Hida J., Yasutomi M., Maruyama T., Nakajima A., Uchida T., Wakano T., et al. Results from pelvic exenteration for locally advanced colorectal cancer with lymph node metastases. Dis Colon Rectum 41 (1998) 165-168
16. Nagtegaal I.D., van de Velde C.J., Marijnen C.A., van Krieken J.H., and Quirke P. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 20 (2005) 9257-9264
17. Birbeck K.F., Macklin C.P., Tiffin N.J., Parsons W., Dixon M.F., Mapstone N.P., et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235 (2002) 449-457
18. Wibe A., Rendedal P.R., Svensson E., Norstein J., Eide T.J., Myrvold H.E., et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89 (2002) 327-334
19. Vermaas M., Ferenschild F.T., Verhoef C., Nuyttens J.J., Marinelli A.W., Wiggers T., et al. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 33 (2007) 452-458
20. Nagawa H., Muto T., Sunouchi K., Higuchi Y., Tsurita G., Watanabe T., et al. Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44 (2001) 1274-1280
21. Johnson P.M., Porter G.A., Ricciardi R., and Baxter N.N. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 1 (2006) 3570-3575
22. Swanson R.S., Compton C.C., Stewart A.K., and Bland K.I. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10 (2003) 65-71
23. Caplin S., Cerottini J.P., Bosman F.T., Constanda M.T., and Givel J.C. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 83 (1998) 666-672
24. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., Putter H., Steup W.H., Wiggers T., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
25. Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal Carcinoma. 1st English ed (1997), Kanehara Shuppan, Tokyo
26. Heald R.J., Moran B.J., Ryall R.D., Sexton R., and MacFarlane J.K. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 133 (1998) 894-899
27. Moriya Y., Sugihara K., Akasu T., and Fujita S. Patterns of recurrence after nerve-sparing surgery for rectal adenocarcinoma with special reference to loco-regional recurrence. Dis Colon Rectum 38 (1995) 1162-1168
28. Balbay M.D., Slaton J.W., Trane N., Skibber J., and Dinney C.P. Rationale for bladder-sparing surgery in patients with locally advanced colorectal carcinoma. Cancer 86 (1999) 2212-2216
29. Gerard J.P., Conroy T., Bonnetain F., Bouche O., Chapet O., Closon-Dejardin M.T., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625